ROYAL BANK OF CANADA - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 16 filers reported holding AVENUE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$0554
+7.8%
0.00%
Q4 2023$0514
+424.5%
0.00%
Q3 2023$098
+88.5%
0.00%
Q2 2023$052
-5.5%
0.00%
Q1 2023$0550.0%0.00%
Q4 2022$0550.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 553,338$647,4050.53%
EMFO, LLC 533$6240.00%
WELLS FARGO & COMPANY/MN 4,585$5,3650.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 52,571$60,4560.00%
BlackRock Inc. 1,942$2,2720.00%
Bank of New York Mellon Corp 52,986$61,9940.00%
BARRETT & COMPANY, INC. 15$170.00%
Tower Research Capital LLC (TRC) 5,629$6,5860.00%
MORGAN STANLEY 414$4840.00%
View complete list of AVENUE THERAPEUTICS INC shareholders